首页> 外国专利> Method of manufacturing aseptic injectable implant at the base of the acrylic polymer polimetlmetacrilato plus sodium carboxy methyl cellulose, and acid etilenodiaminotetacu00e9tico ringer without lactate in the gel form viscous sterile.

Method of manufacturing aseptic injectable implant at the base of the acrylic polymer polimetlmetacrilato plus sodium carboxy methyl cellulose, and acid etilenodiaminotetacu00e9tico ringer without lactate in the gel form viscous sterile.

机译:在丙烯酸​​聚合物polimetlmetacrilato加羧甲基纤维素钠和无乳酸酯的酸式无菌环糊精的基础上制造无菌可注射植入物的方法。

摘要

Title: aseptic manufacturing injectable implant based polimetlmetacrilato spheres. The technical sector: a61k (Classification IPC); the bioplasty technique is a technique slightly invasive for the introduction of biomaterials in the body with the main objective of improving aesthetic. The invention in question refers to a method of manufacturing an injectable implant used in extension.The implant is characterized by the suspension of the acrylic polymer cement in a vehicle comprising sodium carboxymethyl cellulose, ringer and ethylenediaminetetraacetic acid in the form of an opaque white viscous gel.For its manufacture is required the acquisition of polymethylmethacrylate spheres in the size of 35 to 45 microns in the concentration of up to 50%, according to studies are sufficient for a great effect in addition to reduce the possibility of inadvertent absorption by the body, the completion of the The manufacturing process of the injectable implant with the following formulation: polymethylmethacrylate.Sodium carboxymethyl cellulose of pharmaceutical grade, ethylenediaminetetraacetic acid and an injectable solution of Ringer's solution and make the manipulation, mixing and filling aseptic manner, without the need of sterilization in the final product.
机译:标题:无菌制造基于可注射植入物的polimetlmetacrilato球。技术部门:a61k(IPC分类);生物整形技术是一种微创技术,旨在将生物材料引入体内,其主要目的是改善美学。所讨论的发明涉及一种用于延伸的可注射植入物的制造方法。该植入物的特征在于丙烯酸聚合物胶粘剂以不透明的白色粘性凝胶形式悬浮在包含羧甲基纤维素钠,林格和乙二胺四乙酸的媒介物中。根据制造商的研究结果,需要获得浓度为50%至35%的尺寸为35至45微米的聚甲基丙烯酸甲酯球体,除了减少人体意外吸收的可能性外,还足以产生很大的效果,完成以下配方的可注射植入物的制造过程:聚甲基丙烯酸甲酯。药用级羧甲基纤维素钠,乙二胺四乙酸和林格氏溶液的可注射溶液,并以无菌方式进行操作,混合和填充,无需灭菌在最终产品中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号